**Core Concept**
The transfer of drugs across the placenta is a critical aspect of fetal pharmacology, governed by the principles of diffusion, active transport, and receptor-mediated transport. The placental barrier allows certain substances to pass through, while others are restricted due to their molecular size, charge, or lipid solubility.

**Why the Correct Answer is Right**
The transfer of drugs across the placenta is a complex process influenced by the fetal and maternal plasma concentrations, the molecular weight of the drug, and the presence of specific receptors or transporters. Lipid-soluble drugs can diffuse through the placental membranes, while polar or charged substances are restricted due to the relatively impermeable nature of the placental barrier. In addition, the placenta expresses various transporters, such as P-glycoprotein (P-gp), which can efflux drugs from the fetus back into the maternal circulation.

**Why Each Wrong Option is Incorrect**
**Option A:** This statement is true. The placenta is a dynamic organ capable of adapting to changes in maternal and fetal requirements, including the transfer of essential nutrients and waste products.

**Option B:** This statement is true. The transfer of certain drugs across the placenta can lead to fetal exposure and potential harm, highlighting the importance of careful consideration during pregnancy.

**Option C:** This statement is false. The placenta is not a significant source of drug metabolism, unlike the liver, which is responsible for the majority of drug metabolism in the fetus and mother.

**Clinical Pearl / High-Yield Fact**
The placental transfer of drugs can be influenced by various factors, including the presence of specific transporters, fetal and maternal plasma concentrations, and the molecular weight of the drug. A thorough understanding of these factors is essential for safe and effective medication use during pregnancy.

**Correct Answer: C. The placenta is not a significant source of drug metabolism.**